Emerging role of adipokines in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by multisystem organ involvement and unclear pathogenesis. Several adipokines synthesized in the adipose tissue, including leptin, adiponectin, resistin, and chemerin, have been explored in autoimmune rheumatic disease...

Full description

Saved in:
Bibliographic Details
Published inImmunologic research Vol. 64; no. 4; pp. 820 - 830
Main Authors Li, Hong-Miao, Zhang, Tian-Ping, Leng, Rui-Xue, Li, Xiang-Pei, Li, Xiao-Mei, Liu, Hai-Rong, Ye, Dong-Qing, Pan, Hai-Feng
Format Journal Article
LanguageEnglish
Published New York Springer US 01.08.2016
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by multisystem organ involvement and unclear pathogenesis. Several adipokines synthesized in the adipose tissue, including leptin, adiponectin, resistin, and chemerin, have been explored in autoimmune rheumatic diseases, especially SLE, and results suggest that these mediators may be implicated in the pathogenesis of SLE. However, the current results are controversial. In this review, we will briefly discuss the expression and possible pathogenic role of several important adipokines, including leptin, adiponectin, resistin, and chemerin in SLE.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0257-277X
1559-0755
DOI:10.1007/s12026-016-8808-8